Enopen Cream (150g)

Product Information

As with all potent topical glucocorticoids, avoid sudden discontinuation of treatment. When long term topical treatment with potent glucocorticoids is stopped, a rebound phenomenon can develop which takes the form of a dermatitis with intense redness, stinging and burning. This can be prevented by slow reduction of the treatment, for instance continue treatment on an intermittent basis before discontinuing treatment. Your doctor or pharmacist will talk to you about which type of emollient will work best for your skin condition.

Please note the Zeroderma range of emollients are now reserved for existing patients that have a documented reason in the notes as to why other products are unsuitable or not tolerated. This makes sure that diverse clinical systems can effectively 'talk' to each other using a common coded language for the transfer of medicines information. at System.Web.Mvc.RazorView.RenderView(ViewContext viewContext, TextWriter writer, Object instance) The dm+d data must be used by systems when information about medicines used in the care of NHS patients is transferred electronically from one system to another. This is to ensure compliance with the SCCI0052 standard. The emollient should be applied as soon as you have patted your skin dry to make sure it's properly absorbed. Skin reactionsSecond line choice Paraffin-Free emollient - where specifically indicated for paraffin sensitive patients or patients using oxygen therapy Should an infection develop, use of an appropriate antifungal or antibacterial agent should be instituted. If a favourable response does not occur promptly, the corticosteroid should be discontinued until the infection is adequately controlled. Barnsley Self-Care Guidance:Guidance on conditions for which over the counter items should not routinely be prescribed in primary care Very common (≥1/10); common (≥1/100, <1/10); uncommon (≥1/1,000, <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10 000,); not known (cannot be estimated from available data) See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

Emollients are moisturising treatments applied directly to the skin to soothe and hydrate it. They cover the skin with a protective film to trap in moisture. Patient Information Leaflet: Skin Creams Alert - Clothing, bedding, dressings and bandages with skin cream dried on them can catch fire easily causing severe and fatal burns dm+d description guidance (Word: 264KB) explains how the dm+d descriptions might be implemented by system suppliers and programmes. Please note the Zeroderma range of emollients are now reserved for existing patients that have a documented reason in the notes as to why other products are unsuitable or not tolerated,

Moisturisers

Ensure that your clothes and bedding are changed regularly (preferably daily) as the paraffin can soak into fabric and can potentially be a fire hazard

Adverse reactions: Mild skin reactions, such as redness and rash, have been seen very rarely. Should this occur, use of the product should be stopped. In the unlikely event of side effects, you should talk to your doctor or pharmacist. This product contains cetostearyl alcohol which may cause local skin reactions. Emollient soap substitutes that are used instead of normal soap in the bath or shower are not usually available on the NHS. How to get emollients The documentation for a particular SNOMED CT UK Drug Extension data release can be found at SNOMED CT UK Drug Extension Release. You can buy emollients from a pharmacy without a prescription. If the skin condition is severe, talk to a GP, nurse or health visitor, as you may need a stronger treatment.Trusts must implement NHS standards in accordance with the NHS Standard Contract and the Health and Social Care Act 2012. at Umbraco.Web.Mvc.ProfilingView.Render(ViewContext viewContext, TextWriter writer) in D:\a\1\s\src\Umbraco.Web\Mvc\ProfilingView.cs:line 25 dm+d Implementation Guide (Primary Care) v5.0 explains how the dm+d might be implemented in a primary care system to support processes such as the Electronic Prescription Service (EPS). Secondary care implementation guidance